Highlights
NASDAQ: ONCE       Spark Therap
Last Price Today's Change   Day's Range   Trading Volume
72.76   0.00 (0.00%)  0.00 - 0.00  0

Overview

 
Avg Volume (4 weeks):469,380
4 Weeks Range:66.13 - 86.51
4 Weeks Price Volatility (%):
84.11%
52 Weeks Range:47.03 - 91.75
52 Weeks Price Volatility (%):
79.30%
Average Price Target:-

Headlines



No recent Headlines for this stock.


Business Background

Spark Therapeutics, Inc. is a gene therapy company. The Company focuses on treating orphan diseases. It has a pipeline of product candidates targeting multiple rare blinding conditions, hematologic disorders and neurodegenerative diseases. Its pipeline includes a product candidate targeting choroideremia (CHM), which is in a Phase I/II clinical trial and a product candidate for hemophilia A, which is in a Phase I/II clinical trial. Its product investigational candidate, voretigene neparvovec, is intended to treat a genetic blinding condition or inherited retinal disease (IRD). The programs targeting hematologic disorders include SPK-FIX, for which the lead product candidate, SPK-9001, is in a Phase I/II clinical trial for the treatment of hemophilia B, as well as SPK-FVIII for the treatment of hemophilia A. In its SPK-FVIII program for the treatment of hemophilia A, the Company has initiated a dose-escalating Phase I/II clinical trial for its lead product candidate, SPK-8011.

  Be the first to like this.
 


 

8485 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 RHE 0.270.00 
 HONE 19.170.00 
 EPHE 37.330.00 
 ENZL 45.000.00 
 FTRPR 12.920.00 
 ABEOW 11.210.00 
 UBIO 30.890.00 
 CIGI 61.950.00 
 IMU.W 0.050.00 
 ESXB 8.400.00 
Partners & Brokers